L-2-oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease

Journal of Clinical Investigation

Volumn 101, Issue 6, 1998, Pages 1408-1414

  Vita, Joseph A ^a,c   Frei, Balz ^a,d   Holbrook, Monika ^a   Gokce, Noyan ^a   Leaf, Cynthia ^b   Keaney Jr , John F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Transcend Therapeutics Inc   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d OREGON STATE UNIVERSITY   (United States)

Author keywords

Antioxidants; Blood vessels; Endothelium; Glutathione; Nitric oxide

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; GLYCERYL TRINITRATE; NITRIC OXIDE;

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

EID: 0032521146     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1155     Document Type: Article

References (66)

1. Vita, J.A., C.B. Treasure, P. Ganz, D.A. Cox, R.D. Fish, and A.P. Selwyn. 1989. Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis. J. Am. Coll. Cardiol. 14:1193-1199.
2. Ludmer, P.L., A.P. Selwyn, T.L. Shook, R.R. Wayne, G.H. Mudge, R.W. Alexander, and P. Ganz. 1986. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315:1046-1051.
3. Vita, J. A., C.B. Treasure, E.G. Nabel, J.M. McLenachan, R.D. Fish, A.C. Yeung, V.I. Vekshtein, A.P. Selwyn, and P. Ganz. 1990. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:491-497.
4. Levine, G.N., J.F. Keaney, Jr., and J.A. Vita. 1995. Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanisms. N. Engl. J. Med. 332:512-521.
5. Keaney, J.F., and J.A. Vita. 1995. Atherosclerosis, oxidative stress and antioxidant protection in endothelium-derived relaxing factor action. Prog. Cardiovasc. Dis. 38:129-154.
6. Ohara, Y., T.E. Peterson, and D.G. Harrison. 1993. Hypercholesterolemia increases endothelial Superoxide anion production. J. Clin. Invest. 91: 2546-2551.
7. Keaney, J.F., Jr., A. Xu, D.C. Cunningham, T. Jackson, B. Frei, and J.A. Vita. 1995. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and Superoxide production. J. Clin. Invest. 95:2520-2529.
8. Rubanyi, G.M., and P.M. Vanhoutte. 1986. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250:H822-H827.
9. Gryglewski, R.J., R.M. Palmer, and S. Moncada. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:454-456.
10. Keaney, J.F., Jr., and B. Frei. 1994. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In Natural Antioxidants in Human Health and Disease. B. Frei, editor. Academic Press, Inc. San Diego. 303-352.
11. Kugiyama, K., S.A. Kerns, J.D. Morrisett, R. Roberts, and P.D. Henry. 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344:160-162.
12. Chin, J.H., S. Azhar, and B.B. Hoffman. 1992. Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins. J. Clin. Invest. 89:10-18.
13. Mugge, A., J.H. Elwell, T.E. Peterson, T.G. Hofmeyer, D.D. Heistad, and D.G. Harrison. 1991. Chronic treatment with polyethylene-glycolated Superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res. 69:1293-1300.
14. Keaney, J.F., Jr., J.M. Gaziano, A. Xu, B. Frei, J. Curran-Celantano, G.T. Shwaery, J. Loscalzo, and J.A. Vita. 1993. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc. Natl. Acad. Sci. USA. 90:11880-11884.
15. Simon, B.C., C.C. Haudenschild, and R.A. Cohen. 1993. Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J. Cardiovasc. Pharmacol. 21:893-901.
16. Anderson, T.J., I.T. Meredith, A.C. Yeung, B. Frei, A. Selwyn, and P. Ganz. 1995. The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332:488-493.
17. Meister, A. 1994. Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269:9397-9400.
18. Ting, H.H., F.K. Timimi, K.S. Boles, S.J. Creager, P. Ganz, and M.A. Creager. 1996. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97:22-28.
19. Heitzer, T., H. Just, and T. Munzel. 1996. Antioxidant vitamin C improves endothelial dysfunction on chronic smokers. Circulation. 94:6-9.
20. Ting, H.H., F.K. Timimi, E.A. Haley, M.A. Roddy, P. Ganz, and M.A. Creager. 1997. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 95:2617-2622.
21. Levine, G.N., B. Frei, S.N. Koulouris, M.D. Gerhard. J.F. Keaney, Jr., and J.A. Vita. 1996. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 96:1107-1113.
22. Ma, X.L., B.L. Lopez, G.L. Liu, T.A. Christopher, F. Gao, Y. Guo, G.Z. Feuerstein, R.R. Ruffolo Jr., F.C. Barone, and T.L. Yue. 1997. Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury. Circ. Res. 80:894-901.
23. Williamson, J.M., and A. Meister. 1981. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate: a 5-oxo-L-prolinase substrate. Proc. Natl. Acad. Sci. USA. 78:936-939.
24. Williamson, J.M., B. Boettcher, and A. Meister. 1982. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc. Natl. Acad. Sci. USA. 79:6246-6249.
25. Boesgaard, S., H.E. Poulsen, J. Aldershvile, S. Loft, M.E. Anderson, and A. Meister. 1993. Acute effects of nitroglycerin depend on both plasma and intracellular sulfhydryl compound levels in vivo: effects of agents with different sulfhydryl modulating properties. Circulation. 87:547-553.
26. Boesgaard, S., J. Aldershvile, H.E. Poulsen, S. Loft, M.E. Anderson, and A. Meister. 1994. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels. Circ. Res. 74:115-120.
27. Porta, P., S. Aebi, K. Summer, and B.H. Lauterburg. 1991. L-2-oxoihiazolidine-4-carboxylic acid, a cysteine prodrug: Pharmacokinetics and effects on thiols in plasma and lymphocytes in humans. J. Pharmacol. Exp. Ther. 257:331-334.
28. Hamsten, A., G. Walldius, A. Szamosi, G. Dahlen, and U. deFaire. 1986. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation. 73:1097-1110.
29. Lieberman, E.H., M.D. Gerhard, A. Uehata, B.W. Walsh, A.P. Selwyn, P. Ganz, A.C. Yeung, and M.A. Creager. 1994. Estrogen improves endothelium-dependent. flow mediated vasodilation in post menopausal women. Ann. Intern. Med. 121:936-941.
30. Lieberman, E.H., M.D. Gerhard, A. Uehata, A.P. Selwyn, P. Ganz, A.C. Yeung, and M.A. Creager. 1996. Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease. Am. J. Cardiol. 78:1210-1214.
31. Vita, J.A., and J.F. Keaney, Jr. 1996. Ultrasound assessment of endothelial vasomotor function. In Diagnostics of Vascular Diseases: Principals and Technology. P. Lanzer, and M. Lipton, editors. Springer-Verlag, Berlin. 249-259.
32. Assman, G., H. Schreiwer, G. Schmitz, and E.O. Hagele. 1983. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgC12. Clin. Chem. 29:2026-2030.
33. Friedewald, W.T., R.I. Levy, and D.S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:499-502.
34. Frei, B., L. England, and B.N. Ames. 1989. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA. 86:6377-6381.
35. Fiskerstrand, T., H. Refsum, G. Kvalheim, and P.M. Ueland. 1993. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin. Chem. 39:263-271.
36. Winkler, B.S. 1987. In vitro oxidation of ascorbic acid and its prevention by GSH. Biochim. Biophys. Acta. 925:258-264.
37. Martensson, J.J., E.W. Han, A. Griffith, and A. Meister. 1993. Glutathione delays the onset of scurvy in ascorbate-deficient guinea pigs. Proc. Natl. Acad. Sci. USA. 90:317-321.
38. Hecker, M., I. Siegle, H. Macarthur, W.C. Sessa, and J.R. Vane. 1992. Role of intracellular thiols in release of EDRF from cultured endothelial cells. Am. J. Physiol. 262:H888-H896.
39. Murphy, M.E., H.-M. Piper, H. Watanabe, and H. Sies. 1991. Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J. Biol. Chem. 266:19378-19383.
40. Mugge, A., J.K. Elwell, T.E. Peterson, and D.G. Harrison. 1991. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am. J. Physiol. 260:C219-C225.
41. Ghigo, D., P. Alessio, A. Foco, F. Bussolino, C. Costamagna, R. Heller, G. Garbarino, G.P. Pescarmona, and A. Bosia. 1993. Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells. Am. J. Physiol. 265:C728-C732.
42. Komori, Y., J. Hyun, K. Chiang, and J.M. Fukuto. 1995. The role of thiols in the apparent activation of rat brain nitric oxide synthase (NOS). J. Biochem. 117:923-927.
43. Stuehr, D.J., N.S. Kwon, and C.F. Nathan. 1990. FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem. Biophys. Res. Commun. 168:558-565.
44. Hobbs, A.J., J.M. Fukoto, and L.J. Ignarro. 1994. Formation of free nitric oxide from L-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc. Natl. Acad. Sci. USA. 91:10992-10996.
45. Hofman, H., and H.H.W. Schmidt. 1995. Thiol dependence of nitric oxide synthase. Biochemistry. 34:13443-13452.
46. Howells, D.W., and K. Hyland. 1987. Direct analysis of tetrahydrobiopterin in cerebrospinal fluid by high-performance liquid chromatography with redox electrochemistry: prevention of autooxidation during storage and analysis, Clin. Chim. Acta. 167:23-30.
47. Heales, S., and K. Hyland. 1989. Determination of quinonoid dihydrobiopterin by high-performance liquid chromatography and electrochemical detection. J. Chromatogr. 494:77-85.
48. Patel, J.M., A.J. Abeles, and E.R. Block. 1996. Nitric oxide exposure and sulfhydryl modulation alter L-arginine transport in cultured pulmonary artery endothelial cells. Free Radical Biol. Med. 20:629-637.
49. Heinzel, B., M. John, P. Klatt, E. Böhme, and B. Mayer. 1992. Ca2+/ calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem. J. 281:627-630.
50. Pou, S., W.S. Pou, D.S. Bredt, S.H. Snyder, and G.M. Rosen. 1992. Generation of Superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267: 24173-24176.
51. Xia, Y., V.L. Dawson, T.M. Dawson, S.H. Snyder, and J.L. Zweier. 1996. Nitric oxide synthase generates Superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cell injury. Proc. Natl. Acad. Sci. USA. 93:6770-6774.
52. Martensson, J., and A. Meister. 1991. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: Ascorbate spares glutathione and protects. Proc. Natl. Acad Sci. USA. 88:4656-4660.
53. Wink, D.A., R.W. Nims, J.F. Darbyshire, D. Christodoulou, I. Hanbauer, G.W. Cox, F. Laval, J. Laval, J.A. Cook, and M.C. Krishna. 1994. Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of inter-mediates generated in the NO/O2 reaction. Chemical Res. Toxicol. 7:519-525.
54. Moro, M.A., V. Darlev-Usmar, D.A. Goodwin, N.G. Read, R. Zamora-Pino, M. Feelisch, M.W. Radomski, and S. Moncada. 1994. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc. Natl. Acad. Sci. USA. 91:6702-6706.
55. Stamler, J.S., D.J. Singel, and J. Loscalzo. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1898-1902.
56. Stamler, J.S., M.E. Mendelsohn, P. Amarante, D. Smick, N. Andon, P.F. Davies, J.P. Cooke, and J. Loscalzo. 1989. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ. Res. 65:789-795.
57. Cooke, J.P., J. Stamler, N. Andon, P.F. Davies, G. McKinley, and J. Loscalzo. 1990. Flow stimulates endothelial cells to release nitrovasodilator that is potentiated by reduced thiol. Am. J. Physiol. 259(Pt. 2):H804-H812.
58. Creager, M.A., M.A. Roddy, K. Boles, and J.S. Stamler. 1997. N-acetylcysteine does not influence the activity of endothelium-derived relaxing factor in vivo. Hypertension. 29:668-672.
59. Wong, B.K., H.C. Chan, and G.B. Corcoran. 1986. Selective effects of N-acetylcysteine stereoisomers on hepatic glutathione and plasma sulfate in mice. Toxicol. Appl. Pharmacol. 86:421-429.
60. Celermajer, D.S., K.E. Sorensen, V.M. Gooch, D.J. Spiegelhalter, O.I. Miller, I.D. Sullivan, J.K. Lloyd, and J.E. Deanfield. 1992. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1111-1115.
61. Sorenson, K.E., D.S. Celermajer, and D. Georgakopoulos. 1994. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J. Clin. Invest. 93:50-55.
62. Celermajer, D.S., K.E. Sorensen. C. Bull, J. Robinson, and J.E. Deanfield. 1994. Endothelium-dependent dilation in the systemic arteries of asymptomatic subject relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 24:1468-1474.
63. Treasure, C.B., S.V. Manoukian, J.L. Klein, J.A. Vita, E.G. Nabel, G.H. Renwick, A.P. Selwyn, R.W. Alexander, and P. Ganz. 1992. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ. Res. 71:776-781.
64. Nitenherg, A., P. Valersi, R. Sachs, M. Dali, E. Aptecar, and J.R. Attali. 1993. Impairment of coronary vascular reserve in and ACH-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 42:1017-1025.
65. Nitenberg, A., I. Antony, and J.M. Foult. 1993. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arte-riographic findings. Am. J. Med. 95:71-77.
66. Anderson, T.J., A. Uehata, M.D. Gerhard, I.T. Meredith, S. Knab, D. Delagrange, E. Leiberman, P. Ganz, M.A. Creager, A.C. Yeung, and A.P. Selwyn. 1995. Close relation tit endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. 26:1235-1241.